The news is, on the surface good, however it would not be the first time that one of the major firms has acquired the rights to something in order to suppress it, as GSK did with Biota's Relenza. Hopefully not the case here.
Ann: Bionomics and Merck Collaboration Presentation, page-7
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)